Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2004
Published online before print December 23, 2004, doi: 10.1161/01.RES.0000154263.70223.13
A more recent version of this article appeared on February 4, 2005
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
96/2/148    most recent
01.RES.0000154263.70223.13v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Omura, T.
Right arrow Articles by Yoshikawa, J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Omura, T.
Right arrow Articles by Yoshikawa, J.
Related Collections
Right arrow Animal models of human disease
Right arrow Myocardial cardiomyopathy disease
Right arrowRelated Article

Submitted on October 19, 2004
Revised on December 8, 2004
Accepted on December 14, 2004

Core Protein of Hepatitis C Virus Induces Cardiomyopathy

Takashi Omura *; Minoru Yoshiyama ; Tetsuya Hayashi ; Shuhei Nishiguchi ; Masahiko Kaito ; Shinichiro Horiike ; Katsuhiko Fukuda ; Sakiko Inamoto ; Yasushi Kitaura ; Yasuhiro Nakamura ; Masakazu Teragaki ; Takeshi Tokuhisa ; Hiroshi Iwao ; Kazuhide Takeuchi ; and Junichi Yoshikawa

From the Department of Internal Medicine and Cardiology (T.O., M.Y., Y.N., M.T., K.T., J.Y.), Department of Pharmacology (H.I.), Department of Hepatology (S.N., K.F.), Osaka City University Medical School, Osaka; Third Department of Medicine (T.H., S.I., Y.K.), Osaka Medical College, Osaka; the Third Department of Internal Medicine (M.K., S.H.), Mie University School of Medicine, Mie; and the Department of Developmental Genetics (T.T.), Chiba University Graduate School of Medicine, Chiba, Japan.

* To whom correspondence should be addressed. E-mail: omura{at}med.osaka-cu.ac.jp.

Hepatitis C virus (HCV) has been reported to be associated with cardiomyopathy. However, the mechanism of cardiomyopathy in chronic HCV infection is still unclear. Therefore, we investigate the development of cardiomyopathy in mice transgenic for the HCV-core gene. After the age of 12 months, mice developed cardiomyopathy that appeared as left ventricular dilatation, and systolic and diastolic dysfunction assessed by Doppler echocardiography. Histologically, hypertrophy of cardiomyocytes, cardiac fibrosis, disarray and scarcity of myofibrils, vacuolization and deformity of nuclei, myofibrillar lysis, streaming of Z-bands, and an increased number of bizarre-shaped mitochondria were found in HCV-core transgenic mice. These histological changes are just consistent with cardiomyopathy. In conclusion, the HCV-core protein directly plays an important role in the development of cardiomyopathy.


Key words: hepatitis C virus • core protein • cardiomyopathy


Related Article:

Hepatitis C Virus Infection and Cardiomyopathies
Akira Matsumori
Circ. Res. 2005 96: 144-147. [Full Text] [PDF]



This article has been cited by other articles:


Home page
J. Gen. Virol.Home page
M. Derakhshan, M. M. Willcocks, M. A. Salako, G. E. N. Kass, and M. J. Carter
Human herpesvirus 1 protein US3 induces an inhibition of mitochondrial electron transport.
J. Gen. Virol., August 1, 2006; 87(Pt 8): 2155 - 2159.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
A. Matsumori
Hepatitis C Virus Infection and Cardiomyopathies
Circ. Res., February 4, 2005; 96(2): 144 - 147.
[Full Text] [PDF]